The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Cyclosporin A Suppresses Replication of Hepatitis C Virus Genome in Cultured Hepatocytes
Abstract
Persistent infection of hepatitis C virus (HCV) is a major cause of liver diseases such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Searching for a substance with anti–HCV potential, we examined the effects of a variety of compounds on HCV replication using a HCV subgenomic replicon cell culture system. Consequently, the immunosuppressant cyclosporin A (CsA) was found to have a suppressive effect on the HCV replicon RNA level and HCV protein expression in these cells. CsA also inhibited multiplication of the HCV genome in a cultured human hepatocyte cell line infected with HCV using HCV–positive plasma. This anti–HCV activity of CsA appeared to be independent of its immunosuppressive function. In conclusion, our results suggest that CsA may represent a new approach for the development of anti–HCV therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Ford, R., & Eisenberg, S. (1990) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02934-6 · Cited by 2,720
Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212202 · Cited by 1,658
Mechanisms of action of cyclosporine
Matsuda, S., & Koyasu, S. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00192-2 · Cited by 812
Sheiner, P. A., Schwartz, M. E., Mor, E., Schluger, L. K., Theise, N., Kishikawa, K., Kolesnikov, V., Bodenheimer, H., Emre, S., & Miller, C. M. (1995) · Hepatology · doi:10.1002/hep.1840210107 · Cited by 367
Manipulating Immune Responses with Immunosuppressive Agents that Target NFAT
Kiani, A., Rao, A., & Aramburu, J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80188-0 · Cited by 281
Karpas, A., Lowdell, M. W., Jacobson, S. K., & Hill, F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8351 · Cited by 130
Impact of immunosuppressive therapy on recurrence of hepatitis C
Everson, G. T. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.35852 · Cited by 121
Steinkasserer, A., Harrison, R., Billich, A., Hammerschmid, F., Werner, G., Wolff, B. H., Peichl, P., Palfi, G. E., Schnitzel, W., & Mlynar, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.814-824.1995 · Cited by 110
Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus
Ikeda, M., Sugiyama, K., Mizutani, T., Tanaka, T., Tanaka, K., Sekihara, H., Shimotohno, K., & Kato, N. (1998) · Virus Research · doi:10.1016/s0168-1702(98)00063-x · Cited by 107
Self-citationKato, N., Sugiyama, K., Namba, K., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01047-7 · Cited by 86
Replication of Hepatitis C Virus in Cultured Non‐neoplastic Human Hepatocytes
Kato, N., Ikeda, M., Mizutani, T., Sugiyama, K., Noguchi, M., Hirohashi, S., & Shimotohno, K. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb02101.x · Cited by 77
Self-citationAnalysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes
Ikeda, M., Kato, N., Mizutani, T., Sugiyama, K., Tanaka, K., & Shimotohno, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80347-9 · Cited by 46
Self-citationHepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro.
Kato, N., Shimotohno, K., Tanaka, T., Mizutani, T., Sugiyama, K., & Ikeda, M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1859 · Cited by 35
Self-citationIkeda, M., Sugiyama, K., Mizutani, T., Tanaka, T., Tanaka, K., Shimotohno, K., & Kato, N. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6818 · Cited by 21
Self-citationInhibition of cyclophilin function in HIV-I infection by cyclosporin A
Huss, R. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80541-x · Cited by 7
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Stock, P. G., Barin, B., Murphy, B., Hanto, D., Diego, J. M., Light, J., Davis, C., Blumberg, E., Simon, D., Subramanian, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001197 · Cited by 531
Metadata
- Authors
- Watashi, K., Hijikata, M., Hosaka, M., Yamaji, M., & Shimotohno, K.
- Venue
- Hepatology
- Published
- 2003-11
- Volume
- 38
- Issue
- 5
- Pages
- 1282-1288
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1993496957
- Cited by
- 510
- References
- 19
- FWCI
- 17.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.